Bilaterally Signed Lisinopril HCTZ Award SPE2D223D0005.pdf

Terri Arndt, Manager, Contracts 1/31/2023

CONTRACT NO. SPE2D2-23-D-0005 Page 2 of 22

CONTINUED FROM PAGE 1 BLOCK 29

The following documents are hereby incorporated by reference into the contract award:

Solicitation SPE2D2-21-R-0112

Exelan Pharmaceuticals’ (Exelan) offer dated 06/07/2022 which are being accepted by the

Government to form this contract.

Exelan’s response to negotiations dated 10/18/2022 for round 1 and 12/21/202, which is being accepted by the Government to form this contract. Exelan was not required to submit corrections during rounds 2 and 3 of negotiations.

Exelan’s Final Proposal Revision dated 01/09/2023 is being accepted by the Government to form this contract.

CONTRACT NO. SPE2D2-23-D-0005 Page 3 of 22

19.

ITEM NO.

20.

SCHEDULE OF SUPPLIES/SERVICES

21.

ESTIMATED

QUANTITY

22.

UNIT

23.

UNIT

PRICE

24.

AMOUNT

0001AA

0001AB

0001AC

0001AD

0001AE

0002AA

0002AB

0002AC

0002AD

0002AE

0003AA

0003AB

0003AC

0003AD

0003AE

0004AA

0004AB

0004AC

0004AD

0004AE

0005AA

0005AB

0005AC

0005AD

0005AE

0006AA

0006AB

0006AC

0006AD

0006AE

Lisinopril HCTZ 20 – 12.5 MG Tablet – 90 Count*

National Drug Code (NDC) 76282-0447-90

Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Lisinopril HCTZ 20 – 12.5 MG Tablet – 100 Count

National Drug Code (NDC) 76282-0447-01

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 20 – 12.5 MG Tablet – 500 Count

National Drug Code (NDC) 76282-0447-05

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 20 – 12.5 MG Tablet – 1000 Count

National Drug Code (NDC) 76282-0447-10

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 20 – 25 MG Tablet – 90 Count*

National Drug Code (NDC) 76282-0448-90

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 20 – 25 MG Tablet – 100 Count

National Drug Code (NDC) 76282-0448-01

Base Year

Option Year 1

Option Year 2

81,723

81,723

3,111

3,111

6,236

6,236

22,789

22,789

12,402

12,402

11,476

11,476

BT**

BT

BT

BT

BT

BT

BT

BT

$8.78

$7.53

$6.69

$5.44

$4.85

$9.67

$8.28

$7.36

$5.98

$5.34

$48.33

$41.42

$36.82

$29.92

$26.69

$88.67

$76.01

$67.56

$54.89

$48.98

$12.41

$10.64

$9.46

$7.68

$6.86

$13.65

$11.70

$10.40

$8.45

$7.54

$717,527.94

$615,374.19

$546,726.87

$444,573.12

$396,356.55

$30,083.87

$25,759.08

$22,896.96

$18,603.78

$16,612.74

$301,385.88

$258,295.12

$229,609.52

$186,581.12

$166,438.84

$2,020,700.63

$1,732,191.89

$1,539,624.84

$1,250,888.21

$1,116,205.22

$153,908.82

$131,957.28

$117,322.92

$95,247.36

$85,077.72

$156,647.40

$134,269.20

$119,350.40

$96,972.20

$86,529.04

CONTRACT NO. SPE2D2-23-D-0005 Page 4 of 22

0007AA

0007AB

0007AC

0007AD

0007AE

0008AA

0008AB

0008AC

0008AD

0008AE

0009AA

0009AB

0009AC

0009AD

0009AE

0010AA

0010AB

0010AC

0010AD

0010AE

0011AA

0011AB

0011AC

0011AD

0011AE

0012AA

0012AB

0012AC

0012AD

0012AE

Lisinopril HCTZ 20 – 25 MG Tablet – 500 Count

National Drug Code (NDC) 76282-0448-05

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 20 – 25 MG Tablet – 1000 Count

National Drug Code (NDC) 76282-0448-10

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 10 – 12.5 MG Tablet – 90 Count*

National Drug Code (NDC) 76282-0446-90

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 10 – 12.5 MG Tablet – 100 Count

National Drug Code (NDC) 76282-0446-01

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 10 – 12.5 MG Tablet – 500 Count

National Drug Code (NDC) 76282-0446-05

Base Year

Option Year 1

Option Year 2

Lisinopril HCTZ 10 – 12.5 MG Tablet – 1000 Count

National Drug Code (NDC) 76282-0446-10

Base Year

Option Year 1

Option Year 2

*Package size is unit of use and is subject to Statement of Work - “Preparation for

Delivery” requirement.

**BT = One Bottle

-The quantities specified in the Schedule are estimates only. Reference FAR

52.216-21 Requirements for details.

5,124

5,124

17,011

17,011

36,984

36,984

3,610

3,610

12,639

12,639

BT

BT

BT

BT

BT

BT

$68.25

$58.50

$52.00

$42.25

$37.70

$128.53

$110.17

$97.93

$79.57

$71.00

$8.33

$7.14

$6.35

$5.16

$4.60

$9.17

$7.86

$6.98

$5.67

$5.06

$45.83

$39.29

$34.92

$28.37

$25.32

$83.06

$71.19

$63.28

$51.42

$45.88

$349,713.00

$299,754.00

$266,448.00

$216,489.00

$193,174.80

$2,186,423.83

$1,874,101.87

$1,665,887.23

$1,353,565.27

$1,207,781.00

$308,076.72

$264,065.76

$234,848.40

$190,837.44

$170,126.40

$8,940.75

$7,663.50

$6,805.50

$5,528.25

$4,993.50

$165,446.30

$141,836.90

$126,061.20

$102,415.70

$91,405.20

$1,049,795.34

$899,770.41

$799,795.92

$649,897.38

$579,877.32

CONTRACT NO. SPE2D2-23-D-0005 Page 5 of 22

Continuation of SF 1449…

1. This contract is estimated at $28,235,184.10 (5 years) or $5,647,036.82 (per year) based on the projected demand.

2. Pursuant to FAR 52.215-6, the Place of Manufacture/Performance is as follows:

☐OFFEROR IS THE MANUFACTURER (AT THE FOLLOWING LOCATIONS) OF THE PRODUCTS

OFFERED ON THIS SOLICITATION.

☒OFFEROR IS A DISTRIBUTOR OF THE PRODUCTS OFFERED ON THIS SOLICITATION. THE

PRODUCTS WILL BE MANUFACTURED BY THE FOLLOWING COMPANY AT THE FOLLOWING

LOCATIONS:

Invagen Pharmaceuticals Inc. _

(Name of Manufacturing Company)

7 Oser Avenue, Hauppauge, NY 11788 (Street Address) (Post Office Address Not Acceptable)

Tapas Datta, tapas.datta@cipla.com, 631.231.3233 (U.S.A. Point of Contact, e-Mail Address and U.S.A Telephone Number)

TABLETS, CAPSULES AND PILLS

Item Complete Address of Facility Where

Ingredients are Measured, Weighed, Mixed and Compounded

Point of Contact

Including Phone Number

0001-Lisinopril HCTZ 20-

12.5MG Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0002- Lisinopril HCTZ 20-

12.5MG Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0003- Lisinopril HCTZ 20-

12.5MG Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0004- Lisinopril HCTZ 20-

12.5MG Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

CONTRACT NO. SPE2D2-23-D-0005 Page 6 of 22

0005- Lisinopril HCTZ 20-25MG

Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0006- Lisinopril HCTZ 20-25MG

Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0007- Lisinopril HCTZ 20-25MG

Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0008- Lisinopril HCTZ 20-25MG

Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0009- Lisinopril HCTZ 10-

12.5MG Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0010- Lisinopril HCTZ 20-25MG

Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0011- Lisinopril HCTZ 20-25MG

Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0012- Lisinopril HCTZ 20-25MG

Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

CONTRACT NO. SPE2D2-23-D-0005 Page 7 of 22

PACKAGING

Item Complete Address of Facilities

Where Intermediate Containers will be Filled and Labeled

Point of Contact

Including Phone Number

0001-Lisinopril HCTZ 20-

12.5MG Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0002- Lisinopril HCTZ 20-

12.5MG Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0003- Lisinopril HCTZ 20-

12.5MG Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0004- Lisinopril HCTZ 20-

12.5MG Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0005- Lisinopril HCTZ 20-25MG

Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0006- Lisinopril HCTZ 20-25MG

Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0007- Lisinopril HCTZ 20-25MG

Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0008- Lisinopril HCTZ 20-25MG

Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0009- Lisinopril HCTZ 10-

12.5MG Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

CONTRACT NO. SPE2D2-23-D-0005 Page 8 of 22

0010- Lisinopril HCTZ 20-25MG

Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0011- Lisinopril HCTZ 20-25MG

Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0012- Lisinopril HCTZ 20-25MG

Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

7 Oser Avenue

Hauppauge, NY 11788

Tapas Datta

PACKING

Item Complete Address of

Facilities Where Products will be Packed and Prepared for Shipment

Point of Contact

Including Phone Number

0001-Lisinopril HCTZ 20-

12.5MG Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0002- Lisinopril HCTZ 20-

12.5MG Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0003- Lisinopril HCTZ 20-

12.5MG Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0004- Lisinopril HCTZ 20-

12.5MG Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0005- Lisinopril HCTZ 20-25MG

Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

CONTRACT NO. SPE2D2-23-D-0005 Page 9 of 22

0006- Lisinopril HCTZ 20-25MG

Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0007- Lisinopril HCTZ 20-25MG

Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0008- Lisinopril HCTZ 20-25MG

Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0009- Lisinopril HCTZ 10-

12.5MG Tablet – 90 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0010- Lisinopril HCTZ 20-25MG

Tablet – 100 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0011- Lisinopril HCTZ 20-25MG

Tablet – 500 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

Tapas.datta@cipla.com

631-231-3233

0012- Lisinopril HCTZ 20-25MG

Tablet – 1000 count bottle

Invagen Pharmaceuticals Inc

550 S. Research Place

Central Islip, NY 11722

Tapas Datta

CONTRACT NO. SPE2D2-23-D-0005 Page 10 of 22

Table of Contents

CONTRACT CLAUSES....…………………………………………….………………..……10

FAR 52.212-4 Contract Terms and Conditions – Commercial Products and Commercial Services

(NOV 2021)……………………………………………………………………… ………...…10

FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive

Orders – Commercial Items (OCT 2022) …………………………………………………..….10

Appendix A: Pharmaceutical Prime Vendors .…..……………..…………………

CONTRACT CLAUSES

FAR 52.212-4, Contract Terms and Conditions — Commercial Products and Commercial

Services (NOV 2021) is incorporated in this solicitation by reference. Its full text may be accessed electronically at https://www.ecfr.gov/cgibin/ECFR?SID=efef3c52b917f6248e7b50687672ed94&mc=true&page=br owse. Text is available for viewing in Subpart 52.2 Text of Provisions and Clauses, through either the HTML or PDF Format links.

FAR 52.212-5 -- Contract Terms and Conditions Required to Implement Statutes or

Executive Orders-Commercial Products and Commercial Services (OCT 2022)

a) The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

(1) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or

Statements (JAN 2017) (section 743 of Division E, Title VII, of the Consolidated and

Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).

(2) 52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (NOV 2021) (Section 1634 of

Pub. L. 115-91).

(3) 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video

Surveillance Services or Equipment. (NOV 2021) (Section 889(a)(1)(A) of Pub. L. 115-

232).

(4) 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (NOV

2015).

CONTRACT NO. SPE2D2-23-D-0005 Page 11 of 22

(5) 52.233-3, Protest After Award (AUG 1996) (31 U.S.C. 3553).

(6) 52.233-4, Applicable Law for Breach of Contract Claim (OCT 2004) (Public Laws 108-

77 and 108-78 (19 U.S.C. 3805 note)).

(b) The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting

Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[Contracting Officer check as appropriate.]

_X_ (1) 52.203-6, Restrictions on Subcontractor Sales to the Government (JUN 2020), with Alternate I (NOV 2021) (41 U.S.C. 4704 and 10 U.S.C. 2402).

_X_ (2) 52.203-13, Contractor Code of Business Ethics and Conduct (NOV 2021) (41

U.S.C. 3509).

__ (3) 52.203-15, Whistleblower Protections under the American Recovery and

Reinvestment Act of 2009 (JUN 2010) (Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.)

_X_ (4) 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards

(JUN 2020) (Pub. L. 109-282) (31 U.S.C. 6101 note).

__ (5) [Reserved]

__ (6) 52.204-14, Service Contract Reporting Requirements (OCT 2016) (Pub. L. 111-117, section 743 of Div. C).

__ (7) 52.204-15, Service Contract Reporting Requirements for Indefinite-Delivery

Contracts (OCT 2016) (Pub. L. 111-117, section 743 of Div. C).

_X_ (8) 52.209-6, Protecting the Government's Interest When Subcontracting with

Contractors Debarred, Suspended, or Proposed for Debarment. (NOV 2021) (31 U.S.C.

6101 note).

_X_ (9) 52.209-9, Updates of Publicly Available Information Regarding Responsibility

Matters (OCT 2018) (41 U.S.C. 2313).

__ (10) [Reserved]

__ (11)(i) 52.219-3, Notice of HUBZone Set-Aside or Sole Source Award (OCT 2022) (15

U.S.C. 657a)

__ (ii) Alternate I (MAR 2020) of 52.219-3.

_X_ (12)(i) 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business

Concerns (OCT 2022) (if the offeror elects to waive the preference, it shall so indicate in its offer) (15 U.S.C. 657a).

__ (ii) Alternate I (MAR 2020) of 52.219-4.

CONTRACT NO. SPE2D2-23-D-0005 Page 12 of 22

__ (13) [Reserved]

__ (14)(i) 52.219-6, Notice of Total Small Business Set-Aside (NOV 2020) (15 U.S.C. 644).

__ (ii) Alternate I (Class Deviation 2020-O0008) (MAR 2020) of 52.219-6.

__ (15)(i) 52.219-7, Notice of Partial Small Business Set-Aside (NOV 2020) (15 U.S.C.

644).

__ (ii) Alternate I (Class Deviation 2020-O0008) (MAR 2020) of 52.219-7.

_X_ (16) 52.219-8, Utilization of Small Business Concerns (OCT 2022) (15 U.S.C.

637(d)(2) and (3)).

_X_ (17)(i) 52.219-9, Small Business Subcontracting Plan (OCT 2022) (15 U.S.C.

637(d)(4)).

__ (ii) Alternate I (NOV 2016) of 52.219-9.

_X_ (iii) Alternate II (NOV 2016) of 52.219-9.

__ (iv) Alternate III (JUN 2020) of 52.219-9.

__ (v) Alternate IV (SEP 2021) of 52.219-9.

__ (18)(i) 52.219-13, Notice of Set-Aside of Orders (MAR 2020) (15 U.S.C. 644(r)).

__ (ii) Alternate I (MAR 2020) of 52.219-13.

__ (19) 52.219-14, Limitations on Subcontracting (Deviation 2021-O0008) (SEP 2021) (15

U.S.C. 637(a)(14)).

_X_ (20) 52.219-16, Liquidated Damages—Subcontracting Plan (SEP 2021) (15 U.S.C.

637(d)(4)(F)(i)).

__ (21) 52.219-27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside)

(OCT 2022) (15 U.S.C. 657f).

_X_ (22)(i) 52.219-28, Post-Award Small Business Program Rerepresentation (OCT 2022)

(15 U.S.C. 632(a)(2)).

__ (ii) Alternate I (MAR 2020) of 52.219-28.

__ (23) 52.219-29, Notice of Set-Aside for, or Sole Source Award to, Economically

Disadvantaged Women-Owned Small Business (EDWOSB) Concerns (OCT 2022) (15

U.S.C. 637(m)).

CONTRACT NO. SPE2D2-23-D-0005 Page 13 of 22

__ (24) 52.219-30, Notice of Set-Aside for, or Sole Source Award to, Women-Owned Small

Business Concerns Eligible Under the Women-Owned Small Business Program (SEP 2021)

(15 U.S.C. 637(m)).

__ (25) 52.219-32, Orders Issued Directly Under Small Business Reserves (MAR 2020) (15

U.S.C. 644(r)).

__ (26) 52.219-33, Nonmanufacturer Rule (SEP 2021) (15 U.S.C. 637(a)(17)).

_X_ (27) 52.222-3, Convict Labor (JUN 2003) (E.O. 11755).

_X_ (28) 52.222-19, Child Labor—Cooperation with Authorities and Remedies (Class

Deviation 2020-O0008) (JAN 2022) (E.O. 13126)

_X_ (29) 52.222-21, Prohibition of Segregated Facilities (APR 2015).

_X_ (30)(i) 52.222-26, Equal Opportunity (SEPT 2016) (E.O. 11246).

__ (ii) Alternate I (Feb 1999) of 52.222-26.

_X_ (31)(i) 52.222-35, Equal Opportunity for Veterans (JUN 2020) (38 U.S.C. 4212).

__ (ii) Alternate I (July 2014) of 52.222-35.

_X_ (32)(i) 52.222-36, Equal Opportunity for Workers with Disabilities (JUN 2020) (29

U.S.C. 793).

__ (ii) Alternate I (July 2014) of 52.222-36.

_X_ (33) 52.222-37, Employment Reports on Veterans (JUN 2020) (38 U.S.C. 4212).

_X_ (34) 52.222-40, Notification of Employee Rights Under the National Labor Relations

Act (DEC 2010) (E.O. 13496).

_X_ (35)(i) 52.222-50, Combating Trafficking in Persons (OCT 2020) (22 U.S.C. chapter 78 and E.O. 13627).

__ (ii) Alternate I (Mar 2015) of 52.222-50 (22 U.S.C. chapter 78 and E.O. 13627).

__ (36) 52.222-54, Employment Eligibility Verification (MAY 2022). (E. O. 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial products or commercial services as prescribed in 22.1803.)

__ (37)(i) 52.223-9, Estimate of Percentage of Recovered Material Content for EPA-

Designated Items (MAY 2008) (42 U.S.C. 6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

__ (ii) Alternate I (MAY 2008) of 52.223-9 (42 U.S.C. 6962(i)(2)(C)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

CONTRACT NO. SPE2D2-23-D-0005 Page 14 of 22

_X_ (38) 52.223-11, Ozone-Depleting Substances and High Global Warming Potential

Hydrofluorocarbons (JUN 2016) (E.O. 13693).

_X_ (39) 52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners (JUN 2016) (E.O. 13693).

__ (40)(i) 52.223-13, Acquisition of EPEAT®-Registered Imaging Equipment (JUN 2014)

(E.O.s 13423 and 13514).

__ (ii) Alternate I (OCT 2015) of 52.223-13.

__ (41)(i) 52.223-14, Acquisition of EPEAT®-Registered Televisions (Jun 2014) (E.O.s

13423 and 13514).

__ (ii) Alternate I (Jun 2014) of 52.223-14.

__ (42) 52.223-15, Energy Efficiency in Energy-Consuming Products (MAY 2020) (42

U.S.C. 8259b).

__ (43)(i) 52.223-16, Acquisition of EPEAT®-Registered Personal Computer Products

(OCT 2015) (E.O.s 13423 and 13514).

__ (ii) Alternate I (Jun 2014) of 52.223-16.

_X_ (44) 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving

(JUN 2020) (E.O. 13513).

_X_ (45) 52.223-20, Aerosols (JUN 2016) (E.O. 13693).

_X_ (46) 52.223-21, Foams (JUN 2016) (E.O. 13693).

__ (47)(i) 52.224-3, Privacy Training (JAN 2017) (5 U.S.C. 552a).

__ (ii) Alternate I (JAN 2017) of 52.224-3.

__ (48) 52.225-1, Buy American—Supplies (NOV 2021) (41 U.S.C. chapter 83).

__ (49)(i) 52.225-3, Buy American—Free Trade Agreements—Israeli Trade Act (NOV

2021) (41 U.S.C. chapter 83, 19 U.S.C. 3301 note, 19 U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43.

__ (ii) Alternate I (JAN 2021) of 52.225-3.

__ (iii) Alternate II (JAN 2021) of 52.225-3.

__ (iv) Alternate III (JAN 2021) of 52.225-3.

__ (50) 52.225-5, Trade Agreements (OCT 2019) (19 U.S.C. 2501, et seq., 19 U.S.C. 3301 note).

CONTRACT NO. SPE2D2-23-D-0005 Page 15 of 22

_X_ (51) 52.225-13, Restrictions on Certain Foreign Purchases (FEB 2021) (E.O.'s, proclamations, and statutes administered by the Office of Foreign Assets Control of the

Department of the Treasury).

__ (52) 52.225-26, Contractors Performing Private Security Functions Outside the United

States (OCT 2016) (Section 862, as amended, of the National Defense Authorization Act for

Fiscal Year 2008; 10 U.S.C. 2302 Note).

__ (53) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (NOV 2007) (42 U.S.C.

5150).

__ (54) 52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area

(NOV 2007) (42 U.S.C. 5150).

_X_ (55) 52.229-12, Tax on Certain Foreign Procurements (FEB 2021)

__ (56) 52.232-29, Terms for Financing of Purchases of Commercial Products and

Commercial Services (NOV 2021) (41 U.S.C.4505, 10 U.S.C. 2307(f)).

__ (57) 52.232-30, Installment Payments for Commercial Products and Commercial

Services (NOV 2021) (41 U.S.C. 4505, 10 U.S.C. 2307(f)).

__ (58) 52.232-33, Payment by Electronic Funds Transfer—System for Award Management

(OCT 2018) (31 U.S.C. 3332).

__ (59) 52.232-34, Payment by Electronic Funds Transfer—Other than System for Award

Management (JUL 2013) (31 U.S.C. 3332).

_X_ (60) 52.232-36, Payment by Third Party (MAY 2014) (31 U.S.C. 3332).

__ (61) 52.239-1, Privacy or Security Safeguards (AUG 1996) (5 U.S.C. 552a).

_X_ (62) 52.242-5, Payments to Small Business Subcontractors (JAN 2017)(15 U.S.C.

637(d)(13)).

_X_ (63)(i) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels

(NOV 2021) ((46 U.S.C. 55305 and 10 U.S.C. 2631).

__ (ii) Alternate I (Apr 2003) of 52.247-64.

__ (iii) Alternate II (Feb 2006) of 52.247-64.

(c) The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services: [Contracting Officer check as appropriate.]

__ (1) 52.222-41, Service Contract Labor Standards (AUG 2018) (41 U.S.C. chapter 67).

CONTRACT NO. SPE2D2-23-D-0005 Page 16 of 22

__ (2) 52.222-42, Statement of Equivalent Rates for Federal Hires (MAY 2014) (29 U.S.C.

206 and 41 U.S.C. chapter 67).

__ (3) 52.222-43, Fair Labor Standards Act and Service Contract Labor Standards-Price

Adjustment (Multiple Year and Option Contracts) (AUG 2018) (29 U.S.C. 206 and 41

U.S.C. chapter 67).

__ (4) 52.222-44, Fair Labor Standards Act and Service Contract Labor Standards—Price

Adjustment (MAY 2014) (29 U.S.C 206 and 41 U.S.C. chapter 67).

__ (5) 52.222-51, Exemption from Application of the Service Contract Labor Standards to

Contracts for Maintenance, Calibration, or Repair of Certain Equipment—Requirements

(MAY 2014) (41 U.S.C. chapter 67).

__ (6) 52.222-53, Exemption from Application of the Service Contract Labor Standards to

Contracts for Certain Services—Requirements (MAY 2014) (41 U.S.C. chapter 67).

__ (7) 52.222-55, Minimum Wages Under Executive Order 13658 (JAN 2022).

__ (8) 52.222-62, Paid Sick Leave Under Executive Order 13706 (JAN 2017) (E.O. 13706).

__ (9) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (JUN 2020)

(42 U.S.C. 1792).

(d) Comptroller General Examination of Record. The Contractor shall comply with the provisions of this paragraph (d) if this contract was awarded using other than sealed bid, is in excess of the simplified acquisition threshold, as defined in FAR 2.101, on the date of award of this contract, and does not contain the clause at 52.215-2, Audit and Records—

Negotiation.

(1) The Comptroller General of the United States, or an authorized representative of the

Comptroller General, shall have access to and right to examine any of the Contractor's directly pertinent records involving transactions related to this contract.

(2) The Contractor shall make available at its offices at all reasonable times the records, materials, and other evidence for examination, audit, or reproduction, until 3 years after final payment under this contract or for any shorter period specified in FAR Subpart 4.7, Contractor Records Retention, of the other clauses of this contract. If this contract is completely or partially terminated, the records relating to the work terminated shall be made available for 3 years after any resulting final termination settlement. Records relating to appeals under the disputes clause or to litigation or the settlement of claims arising under or relating to this contract shall be made available until such appeals, litigation, or claims are finally resolved.

(3) As used in this clause, records include books, documents, accounting procedures and practices, and other data, regardless of type and regardless of form. This does not require the

Contractor to create or maintain any record that the Contractor does not maintain in the ordinary course of business or pursuant to a provision of law.

CONTRACT NO. SPE2D2-23-D-0005 Page 17 of 22

(e)(1) Notwithstanding the requirements of the clauses in paragraphs (a), (b), (c), and (d) of this clause, the Contractor is not required to flow down any FAR clause, other than those in this paragraph (e)(1) of this paragraph in a subcontract for commercial products or commercial services. Unless otherwise indicated below, the extent of the flow down shall be as required by the clause—

(i) 52.203-13, Contractor Code of Business Ethics and Conduct (NOV 2021) (41 U.S.C.

3509).

(ii) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or

Statements (JAN 2017) (section 743 of Division E, Title VII, of the Consolidated and

Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).

(iii) 52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (NOV 2021) (Section 1634 of

Pub. L. 115-91).

(iv) 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video

Surveillance Services or Equipment. (NOV 2021) (Section 889(a)(1)(A) of Pub. L. 115-

232).

(v) 52.219-8, Utilization of Small Business Concerns (OCT 2022) (15 U.S.C. 637(d)(2) and

(3)), in all subcontracts that offer further subcontracting opportunities. If the subcontract

(except subcontracts to small business concerns) exceeds the applicable threshold specified in FAR 19.702(a) on the date of subcontract award, the subcontractor must include 52.219-8 in lower tier subcontracts that offer subcontracting opportunities.

(vi) 52.222-21, Prohibition of Segregated Facilities (APR 2015).

(vii) 52.222-26, Equal Opportunity (SEP 2016) (E.O. 11246).

(viii) 52.222-35, Equal Opportunity for Veterans (JUN 2020) (38 U.S.C. 4212).

(ix) 52.222-36, Equal Opportunity for Workers with Disabilities (JUN 2020) (29 U.S.C.

793).

(x) 52.222-37, Employment Reports on Veterans (JUN 2020) (38 U.S.C. 4212).

(xi) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act

(DEC 2010) (E.O. 13496). Flow down required in accordance with paragraph (f) of FAR clause 52.222-40.

(xii) 52.222-41, Service Contract Labor Standards (AUG 2018)(41 U.S.C. chapter 67).

(xiii) (A) 52.222-50, Combating Trafficking in Persons (NOV 2021) (22 U.S.C. chapter 78 and E.O. 13627).

(B) Alternate I (Mar 2015) of 52.222-50 (22 U.S.C. chapter 78 and E.O. 13627).

CONTRACT NO. SPE2D2-23-D-0005 Page 18 of 22

(xiv) 52.222-51, Exemption from Application of the Service Contract Labor Standards to

Contracts for Maintenance, Calibration, or Repair of Certain Equipment—Requirements

(MAY 2014) (41 U.S.C. chapter 67).

(xv) 52.222-53, Exemption from Application of the Service Contract Labor Standards to

Contracts for Certain Services—Requirements (MAY 2014) (41 U.S.C. chapter 67).

(xvi) 52.222-54, Employment Eligibility Verification (MAY 2022) (E. O. 12989).

(xvii) 52.222-55, Minimum Wages Under Executive Order 13658 (JAN 2022).

(xviii) 52.222-62 Paid Sick Leave Under Executive Order 13706 (JAN 2017) (E.O. 13706).

(xix)(A) 52.224-3, Privacy Training (JAN 2017) (5 U.S.C. 552a).

(B) Alternate I (JAN 2017) of 52.224-3.

(xx) 52.225-26, Contractors Performing Private Security Functions Outside the United

States (OCT 2016) (Section 862, as amended, of the National Defense Authorization Act for

Fiscal Year 2008; 10 U.S.C. 2302 Note).

(xxi) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (JUN 2020)

(42 U.S.C. 1792). Flow down required in accordance with paragraph (e) of FAR clause

52.226-6.

(xxii) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels (NOV

2021) (46 U.S.C. 55305) and 10 U.S.C. 2631). Flow down required in accordance with paragraph (d) of FAR clause 52.247-64.

(2) While not required, the Contractor May include in its subcontracts for commercial products and commercial services a minimal number of additional clauses necessary to satisfy its contractual obligations.

(End of clause)

The Contractor shall comply with any clause or provision that is checked on the following list which, if checked, is included in this contract by reference to implement provisions of law or

Executive orders applicable to acquisitions of commercial items or components.

1. __X__FAR 52.203-3, Gratuities (APR 1984)

2. __X_ FAR 52.204-7 System for Award Management (OCT 2018)

3. __X___ FAR 52.223-22 Public Disclosure of Greenhouse Gas Emissions and Reduction Goals –

Representation (DEC 2016)

4. __X__DFARS 252.203-7000, Requirements Relating to Compensation of Former DoD Officials

(SEP 2011)

5. __X__DFARS 252.203-7003, Agency Office of the Inspector General (AUG 2019)

6. __X__ DFARS 252.203-7005, Representation Relating to Compensation of Former DoD

Officials (SEP 2022)

7. _____ DFARS 252.204-7012, Safeguarding Covered Defense Information and Cyber Incident

Reporting (DEC 2019)

CONTRACT NO. SPE2D2-23-D-0005 Page 19 of 22

8. _____ DFARS 252.204-7013, Limitations on the Use or Disclosure of Information by Litigation

Support Offerors (MAY 2016)

9. _____ DFARS 252.204-7014, Limitations on the Use or Disclosure of Information by Litigation

Support Contractors (MAY 2016)

10. __X___ DFARS 252.204-7015, Notice of Authorized Disclosure of Information for Litigation

Support (MAY 2016)

11. _X__ DFARS 252.205-7000, Provision of Information to Cooperative Agreement Holders

(DEC 1991)

12. _____ DFARS 252.211-7003, Item Unique Identification and Valuation (MAR 2022)

13. _____ DFARS 252.211-7007, Reporting of Government-Furnished Property (MAR 2022)

14. _____ DFARS 252.215-7003, Requirements for Submission of Data Other Than Certified Cost or Pricing Data—Canadian Commercial Corporation (JUL 2012)

15. _____ DFARS 252.215-7004, Requirement for Submission of Data other Than Certified Cost or

Pricing Data—Modifications—Canadian Commercial Corporation (OCT 2013)

16._ __ _ DFARS 252.215-7007, Notice of Intent to Resolicit (JUN 2012)

17. __X__DFARS 252.215-7008, Only One Offer (JUN 2019)

18. __X__DFARS 252.219-7003, Small Business Subcontracting Plan (DoD Contracts) – Basic

(DEC 2019)

a. _____Alternate I (DEC 2019) of 252.219-7003

b. ____ Alternate II (Dec 2019) of 252.219-7003

19. _____ DFARS 252.219-7004, Small Business Subcontracting Plan (Test Program) (MAY 2019)

20. __X__DFARS 252.223-7008, Prohibition of Hexavalent Chromium (JUN 2013)

21. _____ DFARS 252.225-7000, Buy American—Balance of Payments Program Certificate (NOV

2014)

a. _____Alternate I (NOV 2014) of 52.225-7000

22. _____ DFARS 252.225-7001, Buy American and Balance of Payments Program - Basic (JUN

2022)

a. _____Alternate I (JUN 2017) of 252.225-7001

23. _____ DFARS 252.225-7008, Restriction on Acquisition of Specialty Metals (DEC 2014)

24. __X___ DFARS 252.225-7009, Restriction on Acquisition of Certain Articles Containing

Specialty Metals (DEC 2019)

25. _____ DFARS 252.225-7010, Commercial Derivative Military Article—Specialty Metals

Compliance Certificate (JUL 2009)

26. ___X_ DFARS 252.225-7012, Preference for Certain Domestic Commodities (MAR 2022)

27. _____ DFARS 252.225-7015, Restriction on Acquisition of Hand or Measuring Tools (JUN

2005)

28. _____ DFARS 252.225-7016, Restriction on Acquisition of Ball and Roller Bearings (JUN

2011)

29. _______ DFARS 252.225-7017, Photovoltaic Devices (MAR 2022)

30. _____ DFARS 252.225-7018, Photovoltaic Devices—Certificate (MAR 2022)

31. __X _ DFARS 252.225-7020, Trade Agreements Certificate (NOV 2014)

a. _____ Alternate I (NOV 2014) of 252.225-7020

32. __X__ DFARS 252.225-7021, Trade Agreements (MAR 2022)

a. _____Alternate II (MAR 2022) of 252.225-7021

33. _____ DFARS 252.225-7023, Preference for Products or Services from Afghanistan (SEP 2013)

34. _____ DFARS 252.225-7024, Requirement for Products or Services from Afghanistan (SEP

2013)

35. _____ DFARS 252.225-7026, Acquisition Restricted to Products or Services from Afghanistan

(SEP 2013)

CONTRACT NO. SPE2D2-23-D-0005 Page 20 of 22

36. _____ DFARS 252.225-7027, Restriction on Contingent Fees for Foreign Military Sales (APR

2003)

37. _____ DFARS 252.225-7028, Exclusionary Policies and Practices of Foreign Governments

(APR 2003)

38. _____ DFARS 252.225-7029, Acquisition of Uniform Components for Afghan Military or

Afghan National Police (SEP 2013)

39. __X___ DFARS 252.225-7031, Secondary Arab Boycott of Israel (JUN 2005)

40. _____ DFARS 252.225-7035, Buy American—Free Trade Agreements—Balance of Payments

Program Certificate (Class Deviation 2020-O0019) (JUL 2020)

a. _____Alternate II (Class Deviation 2020-O0019) (JUL 2020) of 252.225-7035 b._____Alternate IV (Class Deviation 2020-O0019) (JUL 2020) of 252.225-7035

c. _____Alternate V (Class Deviation 2020-O0019) (JUL 2020) of 252.225-7035

41. _____ DFARS 252.225-7036, Buy American --Free Trade Agreements--Balance of Payment

Program - Basic (JUN 2022)

a. _____Alternate I (MAR 2022) of 252.225-7036

b. _____Alternate II (JUN 2022) of 252.225-7036

c. _____Alternate III (MAR 2022) of 252.225-7036

d. _____Alternate IV (JUN 2022) of 252.225-7036

e. _____Alternate V (JUN 2022) of 252.225-7036

42. _____ DFARS 252.225-7040, Contractor Personnel Supporting U.S. Armed Forces Deployed

Outside the United States (OCT 2015)

43. _____ DFARS 252.225-7043, Antiterrorism/Force Protection Policy for Defense Contractors

Outside the United States (JUN 2015)

44. __X__ DFARS 252.225-7052, Restrictions on the Acquisition of Certain Magnets, Tantalum, and Tungsten (AUG 2022)

45. __X__ DFARS 252.226-7001, Utilization of Indian Organizations, Indian-Owned Economic

Enterprises, and Native Hawaiian Small Business Concerns (APR 2019)

46. _____ DFARS 252.227-7013, Rights in Technical Data – Noncommercial Items (FEB 2014)

47. _____ DFARS 252.227-7015, Technical Data -- Commercial Items (FEB 2014)

48. _____ DFARS 252.227-7037, Validation of Restrictive Markings on Technical Data (APR

2022)

49. ____ DFARS 252.232-7003, Electronic Submission of Payment Requests and Receiving

Reports (DEC 2018)

50. _____ DFARS 252.232-7009, Mandatory Payment by Governmentwide Commercial Purchase

Card (MAY 2018)

51. __X__ DFARS 252.232-7010, Levies on Contract Payments (DEC 2006)

52. _____ DFARS 252.232-7011, Payments in Support of Emergencies and Contingency

Operations (MAY 2013)

53. _____ DFARS 252.237-7010, Prohibition on Interrogation of Detainees by Contractor

Personnel (JUN 2013)

54. _____ DFARS 252.237-7019, Training for Contractor Personnel Interacting with Detainees

(JUN 2013)

55. _ DFARS 252.239-7017, Notice of Supply Chain Risk (FEB 2019)

56. _____ DFARS 252.239-7018, Supply Chain Risk (FEB 2019)

57. __X__ DFARS 252.243-7002, Requests for Equitable Adjustment (DEC 2012)

58. __X__ DFARS 252.244-7000, Subcontracts for Commercial Items (JAN 2021)

59. DFARS 252.246-7003, Notification of Potential Safety Issues (JUN 2013)

60. _____ DFARS 252.246-7004, Safety of Facilities, Infrastructure, and Equipment for Military

Operations (OCT 2010)

CONTRACT NO. SPE2D2-23-D-0005 Page 21 of 22

61. _____DFARS 252.247-7003, Pass-Through of Motor Carrier Fuel Surcharge Adjustment to the

Cost Bearer (JUN 2013)

62. __X__ DFARS 252.247-7022, Representation of Extent of Transportation by Sea (JUN 2019)

63. __X__DFARS 252.247-7023, Transportation of Supplies by Sea (FEB 2019).

a. Alternate I (FEB 2019) of 252.247-7023.

b. _____ Alternate II (FEB 2019) of 252.247-7023

64. __ __ DFARS 252.247-7025, Reflagging or Repair Work (JUN 2005)

65. _____ DFARS 252.247-7026, Evaluation Preference for Use of Domestic Shipyards –

Applicable to Acquisition of Carriage by Vessel for DoD Cargo in the Coastwise or Noncontiguous

Trade (NOV 2008)

66. _____DFARS 252.247-7027, Riding Gang Member Requirements (MAY 2018)

67. _____ DFARS 252.247-7028, Application for U.S Government Shipping

Documentation/Instructions (JUN 2012)

In addition to the clauses listed in paragraph (e) of FAR 52.212-5, Contract Terms and Conditions

Required to Implement Statutes or Executive Orders-Commercial Items, the Contractor shall include the terms of the following clauses, if applicable, in subcontracts for commercial items or commercial components, awarded at any tier under this contract:

1. DFARS 252.227-7013, Rights in Technical Data – Noncommercial Items (FEB 2014)

2. DFARS 252.227-7015, Technical Data – Commercial Items (FEB 2014)

3. DFARS 252.227-7037, Validation of Restrictive Markings on Technical Data (SEP 2016)

4. DFARS 252.237-7010, Prohibition on Interrogation of Detainees by Contractor Personnel (JUN

2013)

5. DFARS 252.237-7019, Training for Contractor Personnel Interacting with Detainees (JUN 2013)

6. DFARS 252.247-7003, Pass-Through of Motor Carrier Fuel Surcharge Adjustment to the Cost

Bearer (JUN 2013)

7. DFARS 252.247-7023, Transportation of Supplies by Sea (FEB 2019)

CONTRACT NO. SPE2D2-23-D-0005 Page 22 of 22

Appendix A: Pharmaceutical Prime Vendors

The following list represents the current Pharmaceutical Prime Vendors as of the date of this solicitation. The Contractor will be given notice via e-mail within 10 business days if a change occurs to the following list:

Amerisource Bergen Drug Co.

9900 J.E.B. Stuart Parkway

POC: Mr. Alex Merritt

Director of Government Accounts

Phone: 312-533-8015 amerritt@amerisourcebergen.com

Cardinal Health

3651 Birchwood Drive

Waukegan, IL 60085

POC: Maria Tanner

Manager, Government Contract Administration

Cardinal Health

Direct: 847-785-4840

Fax: 614-495-5489

Maria.tanner@cardinalhealth.com

Dakota Drug, Inc.

28 N. Main Street, Box 5009

Minot, ND 58702

POC: Ms. Penny McCormack

Phone: 701-852-2141 x1122

Fax: 763-421-0661 pmccormack@dakdrug.com

DMS Pharmaceutical Group Inc.

810 Busse Highway

Park Ridge, IL 60068

POC: Mr. Misko Dragin, Comptroller

Phone: 847-518-1100 x229

Fax: 847-518-1105 mdragin@dmspharma.com

McKesson Corp.

1220 Senlac Drive

Carrollton, TX 75006

POC: Ms. Lori White, V.P. Government

Phone: 972-446-5758

Fax: 972-446-5337 lori.white@mckesson.com